期刊
JOURNAL OF CLINICAL PERIODONTOLOGY
卷 45, 期 2, 页码 204-212出版社
WILEY
DOI: 10.1111/jcpe.12838
关键词
alveolar bone loss prevention; inflammation; Lactobacillus rhamnosus GG; periodontitis; probiotic
资金
- Australian Dental Research Foundation (ADRF) [57-2015]
AimThis study investigated the role of Lactobacillus rhamnosus GG (LGG) on bone loss and local and systemic inflammation in an in vivo mouse model of experimental periodontitis (PD). Materials and MethodsExperimental PD was induced in mice by oral inoculation with Porphyromonas gingivalis and Fusobacterium nucleatum over a period of 44days. The probiotic LGG was administered via oral inoculation or oral gavage prior to, and during disease induction. The antimicrobial activity of LGG on the inoculum was also tested. Alveolar bone levels and gingival tissue changes were assessed using in vivo microcomputed tomography and histological analysis. Serum levels of mouse homologues for IL-8 were measured using multiplex assays. ResultsPre-treatment with probiotics either via oral gavage or via oral inoculation significantly reduced bone loss (p<.0001) and gingival inflammation (p<.0001) when compared with PD group. Oral gavage treatment group had significantly less tartrate-resistant acid phosphatase positive cells (p<.02) then PD group. LGG showed no antimicrobial activity against P.gingivalis and F.nucleatum. ConclusionsLactobacillus rhamnosus GG effectively suppresses bone loss in a mouse model of induced PD irrespective of the mode of administration.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据